Therefore, from this perspective, the evaluation of bFGF expression in the postoperative phase would be useful both as a discriminating factor by type of PTC and in the further evaluation of the risk of recurrence; thus, it would provide helpful assistance in the diagnosis and identification of thyroid cancer [163]. The gene discussed is FGF2; the disease is thyroid cancer.